In a patient with mild sleep apnea and HFpEF (heart failure with preserved ejection fraction) who is using BiPAP (bilevel positive airway pressure) at static IPAP (inspiratory positive airway pressure) 13 cm H₂O and EPAP (expiratory positive airway pressure) 9 cm H₂O, with an AHI (apnea‑hypopnea index) around 2 but predominantly central apneas clustering in the early morning, should the pressure be increased and switched to a variable‑pressure mode rather than remain static?

Recommendation for BiPAP Management in HFpEF with Clustered Central Apneas

You should switch from static BiPAP to adaptive servo-ventilation (ASV) or bilevel PAP with a backup rate, rather than simply increasing static pressures, as your patient's clustered central apneas in HFpEF require dynamic pressure support with a backup respiratory rate to effectively suppress these events. 1

Why Static Pressure Adjustment Won't Work

Your current approach of static BiPAP at 13/9 cm H₂O is fundamentally the wrong modality for central sleep apnea. The 2025 AASM guideline explicitly suggests against using bilevel PAP without a backup rate for CSA in any etiology, including CSA due to medical conditions like heart failure 1. Static BiPAP cannot respond to the absence of respiratory drive that characterizes central apneas—it simply maintains fixed pressures regardless of whether the patient is making respiratory effort.

The clustering pattern you describe (early morning central apneas) is particularly concerning because it suggests periods of ventilatory instability that static pressures cannot address. Simply increasing your IPAP/EPAP will not provide respiratory support during apneic periods when the patient has no inspiratory effort.

The Right Therapeutic Options

First-Line: Bilevel PAP with Backup Rate

The AASM suggests using bilevel positive airway pressure with a backup rate over no treatment for CSA due to medical conditions 1. This mode provides:

• Mandatory breaths when the patient fails to initiate respiration
• Dynamic support that responds to central events
• Maintained pressure support during periods of normal breathing

Research demonstrates that flow-targeted dynamic bilevel PAP support effectively suppresses CSA in heart failure patients, reducing AHI from 22 events/h on static CPAP/BiPAP to 4 events/h 2. Patients with pure CSA who were unresponsive to CPAP showed significant improvement with bilevel PAP titration 3.

Alternative: Adaptive Servo-Ventilation (ASV)

The AASM suggests using adaptive servo-ventilation for CSA due to medical conditions 1. However, there's a critical caveat for your HFpEF patient: Treatment with ASV in patients with heart failure with reduced ejection fraction should be limited to centers with experience, along with close monitoring and follow-up 1.

Since your patient has HFpEF (preserved ejection fraction), not HFrEF, ASV is safer in this context. Recent case evidence shows successful ASV adaptation in HFpEF patients with CSA who failed CPAP, demonstrating normalization of hypoxic burden and optimal adherence 4.

Clinical Algorithm for Your Patient

Immediate action:

1. Switch to bilevel PAP with backup rate as the most appropriate first step

   • Set EPAP at current level (9 cm H₂O) to maintain upper airway patency
   • Set IPAP at 13-15 cm H₂O for adequate pressure support
   • Add backup rate at 2-4 breaths below the patient's spontaneous rate (typically 12-15 breaths/min)
   • This ensures mandatory ventilation during central apneic periods

2. If bilevel with backup rate fails (residual AHI >10 or persistent symptoms):

   • Transition to ASV with dynamic pressure adjustment
   • ASV automatically adjusts pressure support breath-by-breath to stabilize ventilation
   • Particularly effective for the clustered pattern you're observing 2

3. Optimize underlying HFpEF management concurrently:

   • The AASM emphasizes that clinicians must prioritize optimizing therapy for conditions contributing to central apneas rather than solely focusing on eliminating events 1
   • Ensure volume status is optimized
   • Review medications that may worsen CSA

Important Caveats

Don't be fooled by the low AHI of 2: The clustering pattern means the physiologic impact (sympathetic surges, sleep fragmentation, hypoxemia) is concentrated in short periods, making the overall AHI misleadingly benign. This is exactly the scenario where event-responsive therapy (backup rate or ASV) outperforms static pressure.

Monitor for treatment-emergent issues: Some patients develop complex sleep apnea when transitioning modes. Follow-up polysomnography or download data after 1-3 months is essential.

HFpEF-specific considerations: Your patient's HFpEF makes them particularly vulnerable to the hemodynamic consequences of recurrent central apneas 5, 6. CSA in HFpEF is associated with more advanced heart failure and higher NT-proBNP levels 5, making effective treatment more urgent.

The evidence strongly supports that variable pressure with backup respiratory support—not higher static pressures—is the appropriate intervention for your patient's central apnea pattern.